Solvonis Therapeutics Statistics

Total Valuation

LON:SVNS has a market cap or net worth of GBP 3.79 million. The enterprise value is 3.03 million.

Market Cap	3.79M
Enterprise Value	3.03M

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

LON:SVNS has 2.30 billion shares outstanding. The number of shares has increased by 1,011.63% in one year.

Current Share Class	n/a
Shares Outstanding	2.30B
Shares Change (YoY)	+1,011.63%
Shares Change (QoQ)	+11.10%
Owned by Insiders (%)	46.20%
Owned by Institutions (%)	48.02%
Float	1.22B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	1.23
P/TBV Ratio	3.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.91
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.85

Current Ratio	6.85
Quick Ratio	6.66
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-23.56

Financial Efficiency

Return on equity (ROE) is -56.63% and return on invested capital (ROIC) is -36.64%.

Return on Equity (ROE)	-56.63%
Return on Assets (ROA)	-33.44%
Return on Invested Capital (ROIC)	-36.64%
Return on Capital Employed (ROCE)	-48.90%
Revenue Per Employee	n/a
Profits Per Employee	-530,000
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.30% in the last 52 weeks. The beta is 1.62, so LON:SVNS's price volatility has been higher than the market average.

Beta (5Y)	1.62
52-Week Price Change	-10.30%
50-Day Moving Average	0.16
200-Day Moving Average	0.18
Relative Strength Index (RSI)	59.54
Average Volume (20 Days)	4,533,110

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-1.51M
Pretax Income	-1.45M
Net Income	-1.59M
EBITDA	-1.34M
EBIT	-1.51M
Earnings Per Share (EPS)	-0.00

Full Income Statement

Balance Sheet

The company has 757,000 in cash and n/a in debt, giving a net cash position of 757,000 or 0.00 per share.

Cash & Cash Equivalents	757,000
Total Debt	n/a
Net Cash	757,000
Net Cash Per Share	0.00
Equity (Book Value)	3.08M
Book Value Per Share	0.00
Working Capital	696,000

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.13M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:SVNS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,011.63%
Shareholder Yield	-1,011.63%
Earnings Yield	-41.97%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a